Renzapride in IBS: is efficacy in the eye of the beholder? - Atlantic Healthcare

HEALTHCARE PROFESSIONALS
CONTACT US

About
Research
Therapeutic Focus
Pipeline
Investors
News
- Conferences

Search

HEALTHCARE PROFESSIONALS
CONTACT US

Ford AC (2010)

Alimentary Pharmacology and Therapeutics, 113

Recent Posts

Atlantic Healthcare Supports Rare Disease Day
26th February 2021
Atlantic Healthcare to attend WuXi Global Forum, January 11-13th 2021
8th January 2021
Atlantic Healthcare invited to attend the JP Morgan Healthcare Conference 2021
8th January 2021
Featured in Nature magazine…. A lower risk, higher value, late stage pipeline for gastrointestinal diseases
1st December 2020
Atlantic Healthcare plc appoints pharmaceutical industry veteran Allan Cambridge to the Board of Directors
19th November 2020

Follow

Privacy Preference Center

Privacy Preferences